Identification of Cancer-Specific Glycoproteins in Triple-Negative Breast Cancer

被引:0
|
作者
Tseng, L. H.
Argani, P.
Li, Y.
Tian, Y.
Lopez, M. F.
Sarracino, D.
Rezai, T.
Athanas, M.
Krastins, B.
Chan, D. W.
Zhang, H.
机构
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Thermo Fisher Sci, Cambridge, MA USA
[3] VAST Sci, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
313
引用
收藏
页码:72A / 72A
页数:1
相关论文
共 50 条
  • [31] Advanced Triple-Negative Breast Cancer
    Patel, Grisma
    Prince, Alison
    Harries, Mark
    SEMINARS IN ONCOLOGY NURSING, 2024, 40 (01)
  • [32] What is triple-negative breast cancer?
    Irvin, William J., Jr.
    Carey, Lisa A.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (18) : 2799 - 2805
  • [33] Immunotherapy in Triple-Negative Breast Cancer
    Emens, Leisha A.
    CANCER JOURNAL, 2021, 27 (01): : 59 - 66
  • [34] Pembrolizumab in Triple-Negative Breast Cancer
    Altundag, Kadri
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (15): : 1435 - 1436
  • [35] A Review of Triple-Negative Breast Cancer
    Ismail-Khan, Roohi
    Bui, Marilyn M.
    CANCER CONTROL, 2010, 17 (03) : 173 - 176
  • [36] Triple-negative breast cancer: an update
    Boolbol, Susan K.
    Cate, Sarah P.
    BREAST CANCER MANAGEMENT, 2014, 3 (02) : 127 - 129
  • [37] Morphotypes of the triple-negative breast cancer
    Koleckova, M.
    Kolar, Z.
    Ehrmann, J.
    Korinkova, G.
    Trojanec, R.
    VIRCHOWS ARCHIV, 2017, 471 : S296 - S296
  • [38] Metastatic Triple-negative Breast Cancer
    Rakha, E. A.
    Chan, S.
    CLINICAL ONCOLOGY, 2011, 23 (09) : 587 - 600
  • [39] Targeting triple-negative breast cancer
    Kirkpatrick, Peter
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) : 21 - 21
  • [40] Pathogenesis of Triple-Negative Breast Cancer
    Derakhshan, Fatemeh
    Reis-Filho, Jorge S.
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2022, 17 : 181 - 204